Latest Financials News

Biome Australia Limited has delivered record sales revenue in Q4 FY25 alongside positive EBITDA, setting the stage for its first full-year net profit. Strategic product launches and international expansion underpin its strong growth trajectory.

LTR Pharma has initiated commercial distribution of its nasal spray SPONTAN through Australia's Symbion pharmacy network and is advancing ROXUS development for a US launch in early 2026, while expanding its pipeline with a new intranasal treatment for swallowing disorders.

Algorae Pharmaceuticals has advanced its AI-driven drug discovery platform into preclinical validation through a strategic collaboration with the Peter MacCallum Cancer Centre, while progressing its therapeutic pipeline and commercial leadership.

Wia Gold Limited has reported a substantial 38% increase in its Kokoseb Gold Project resource to 2.93 million ounces, with a majority now classified as Indicated, underpinning ongoing scoping study progress and further exploration in Namibia and Côte d’Ivoire.

EMVision Medical Devices has secured ethics approvals for two pivotal clinical studies and received a $400,000 milestone payment, marking significant progress toward commercialising its portable First Responder brain scanner.

Powerhouse Ventures Limited reports its first operating cash profit within a year of restructuring, driven by three distinct business divisions and a strengthened balance sheet.

Freelancer Limited has reported its strongest half-year profit to date, driven by growth across its freelancing, escrow, and freight platforms, while setting ambitious targets for AI productisation and double-digit revenue growth in FY25.

Wildcat Resources has completed a positive Preliminary Feasibility Study for its Tabba Tabba lithium project in Western Australia, confirming a long-life mine with strong financial metrics and a clear path to development.

Prodigy Gold has updated its mineral resources at the Tanami North Project, increasing gold ounces to over half a million, while securing $6.35 million in a recent entitlement offer to fund further exploration and development.

Mach7 Technologies has updated its FY25 guidance, reporting positive cash flow and a solid financial position, while appointing Teri Thomas as its new CEO to steer the company’s next growth phase.

Nova Minerals has launched a 15,000-meter drilling campaign at its Estelle Project targeting gold and antimony, while advancing a US Department of Defense grant application to fast-track its antimony development.

BSA Limited reported a 7% increase in FY25 revenue to $286.8 million and a 42% rise in EBITDA pre-significant items, despite losing key contracts that accounted for 92% of its revenue. The company is undertaking significant restructuring to navigate these challenges.